Leila Alland
2022
In 2022, Leila Alland earned a total compensation of $2.5M as Chief Medical Officer at PMV Pharmaceuticals, a 78% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $132,174 |
|---|---|
| Option Awards | $1,177,183 |
| Salary | $469,758 |
| Stock Awards | $710,964 |
| Total | $2,490,079 |
Alland received $1.2M in option awards, accounting for 47% of the total pay in 2022.
Alland also received $132.2K in non-equity incentive plan, $469.8K in salary and $711K in stock awards.
Rankings
In 2022, Leila Alland's compensation ranked 1,457th out of 5,736 executives tracked by ExecPay. In other words, Alland earned more than 74.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,457 out of 5,736 | 75th |
Division Manufacturing | 728 out of 3,125 | 77th |
Major group Chemicals And Allied Products | 284 out of 1,416 | 80th |
Industry group Drugs | 263 out of 1,317 | 80th |
Industry Pharmaceutical Preparations | 186 out of 963 | 81st |
Source: SEC filing on April 28, 2023.
Alland's colleagues
We found two more compensation records of executives who worked with Leila Alland at PMV Pharmaceuticals in 2022.